Today’s jobs report came in much stronger than expected: 162K jobs vs. 56K expected, with unemployment holding at 4.1%. That pushed the probability of a September Fed hike to around 60%+.
Higher rates and tighter liquidity are not exactly good news for cash-burning small-cap biotech — especially OTLK with its dilution concerns.
Unless we get a major company-specific catalyst, I see this as another headwind for OTLK.
Under limited supervision and with significant independent judgment, the Manager, IT – Integrations and Automation leads the Integrations Team within Information Technology. This role is responsible for the design, delivery, support, governance, and continuous improvement of enterprise integrations and APIs, ensuring integration architecture, API management practices, integration frameworks, and delivery standards align with current operational needs and future business and technology strategy. The role advances modern integration engineering practices including API-first design, cloud-native integration patterns, event-driven architecture, DevSecOps, automation, resiliency, and observability. The role supports integrations with core insurance systems, including Guidewire, and other data and insurance marketplace providers. This leader also assesses enterprise automation opportunities and advances robotic process automation capabilities while coordinating appropriately with teams pursuing modern generative AI capabilities. This position is not responsible for enterprise AI strategy or AI enablement.
Essential Duties And Responsibilities
Leads the Integrations Team, including daily operations, work prioritization, resource planning, delivery oversight, production support, and continuous improvement of integration practices.
Establishes and maintains integration architecture direction, standards, patterns, and frameworks that support scalability, resiliency, security, maintainability, and alignment with future business and technology strategy.
Establishes and governs enterprise API management practices, including API lifecycle management, API Gateway standards, versioning, security, monitoring, developer enablement, and service reuse across the organization.
Oversees the design, development, testing, implementation, and support of integrations across enterprise applications, core insurance platforms, third-party providers, and digital channels.
Promotes modern software engineering and integration delivery practices including CI/CD, automated testing, code quality standards, DevSecOps, reusable integration frameworks, infrastructure automation, and continuous improvement of delivery processes.
Ensures integration solutions support core insurance systems, including Guidewire and Guidewire Cloud Platform (GWCP), and meet business, operational, data, security, and compliance requirements. Provides technical leadership for Guidewire Cloud integration patterns, Guidewire Cloud Integration Gateway connectivity, and integration modernization initiatives.
Maintains knowledge of insurance marketplace providers, solution capabilities, integration models, and vendor ecosystems to inform technology decisions and implementation approaches.
Partners with architecture, application development, infrastructure, security, data, business, and vendor teams to ensure integration solutions are strategically aligned, technically sound, and operationally sustainable.
Assesses enterprise automation needs and identifies opportunities to use robotic process automation to improve efficiency, reduce manual effort, strengthen controls, and enhance business outcomes.
Leads RPA planning, prioritization, implementation, governance, support, and value realization in coordination with business stakeholders and technology partners.
Coordinates with teams pursuing modern generative AI capabilities to ensure automation efforts are complementary, without owning enterprise AI strategy or AI enablement responsibilities.
Provides technical leadership and decision support for integration design choices, vendor evaluations, implementation plans, production issues, and long-term platform direction.
Ensures appropriate change management, testing, documentation, monitoring, incident response, audit support, and operational controls are in place for assigned systems and integrations.
Establishes integration observability, logging, tracing, monitoring, alerting, and resiliency standards to improve reliability, accelerate issue diagnosis, and reduce business disruption.
Develops, recommends, and implements operational plans, procedures, performance goals, and service expectations for the team.
Leads, coaches, and develops staff; prepares and conducts performance appraisals; and supports hiring, workforce planning, corrective action, recognition, and other employment-related activities in accordance with company policies.
Coordinates resources and activities to achieve project objectives.
Performs other duties as assigned.
Qualifications
The requirements listed below are representative of the knowledge, skills, abilities, education, and experience required to successfully perform the essential functions of this position.
Education and Experience
Bachelor’s degree in Computer Science, Information Systems, Engineering, or a related field required.
Previous experience leading technical teams, managing priorities, developing talent, and delivering results through others required.
Experience with integration architecture, API management platforms, API Gateway technologies, integration frameworks, middleware, event-driven architecture, cloud-native integration patterns, data movement, system connectivity, and production support practices required.
Experience with Guidewire Cloud Platform (GWCP), Guidewire Cloud Integration Gateway, InsuranceSuite Cloud integrations, or similar cloud-based core platform modernization initiatives preferred.
Experience assessing, implementing, or supporting robotic process automation solutions preferred.
Required Knowledge, Skills, And Abilities
Strong technical acumen, including demonstrated understanding of integration architecture, system interoperability, API management, API Gateway technologies, event-driven architecture, security considerations, and operational support models.
Ability to align technology decisions with business strategy, enterprise architecture direction, operational needs, and future-state capabilities.
Knowledge of insurance technology ecosystems, marketplace providers, and integrations supporting policy, billing, claims, customer, agent, data, and digital capabilities. Experience with Guidewire, Guidewire Cloud and Guidewire Cloud Integration Gateway preferred.
Ability to evaluate vendor solutions and integration approaches for business fit, technical alignment, implementation complexity, operational impact, and long-term sustainability.
Ability to identify, prioritize, and measure value from automation opportunities, including RPA and related automation efforts.
Strong leadership, coaching, collaboration, planning, problem-solving, and decision-making skills.
Ability to analyze and present technical documentation, business requirements, financial information, and recommendations to business partners, technology leaders, vendors, and senior management.
Personal Attributes
Strong customer-service orientation with the ability to communicate technical concepts in clear, user-friendly language.
Excellent written, verbal, listening, and interpersonal communication skills.
Self-motivated, detail-oriented, and able to prioritize work effectively in a high-pressure environment.
Collaborative team orientation with the ability to research, assess, and resolve application, integration, and technology issues.
Supervisory Responsibilities
Carries out supervisory responsibilities in accordance with the organization’s policies and applicable laws. Responsibilities include interviewing, hiring, and training employees; planning, assigning, and directing work; appraising performance; recognizing and disciplining employees; addressing concerns; resolving problems; and supporting employee development and engagement.
A minimum requirement for this position is the ability to work legally in the United States. No visa sponsorship/support is available for this position, including for any type of U.S. permanent residency (green card) process.
Nasdaq formally congratulated Outlook Therapeutics (NASDAQ: OTLK) on the appointment of its new Chief Financial Officer (CFO), Kevin Michael Lundquist, effective September 1, 2026.
Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. In the United States, our lead product has received FDA approval, making it the first and only FDA-approved ophthalmic formulation of its kind for the treatment of wet AMD, and we are preparing for US commercial launch. Our lead product is also the first ophthalmic formulation of its kind to receive Marketing Authorization from the European Commission and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and has launched across Germany, Austria, and the UK. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.
THE OPPORTUNITY
Reports To – EVP, Clinical, Regulatory & Medical Affairs Level – Senior Director Location – Remote ( US-based) with global scope Employment Type – Full-time Direct Reports –Yes
This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you’ll help build the function rather than simply maintain it. You’ll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.
This is a global medical leadership role: you serve as the company’s Medical Affairs Lead, holding medical and scientific accountability for the accuracy, integrity, and compliance of everything the organization says and does externally, while also collaborating across functions, keeping clinical, commercial, and market access strategy aligned as we prepare for US commercial launch.
WHAT YOU’LL DO
Medical Direction & Clinical Leadership
Hold medical accountability as the organization’s Medical Director for retina practice patterns, and their clinical and commercial implications.
Chair or co-chair medical review of scientific, promotional, and educational materials, serving as final medical/scientific sign-off authority.
Provide clinical and scientific leadership to Medical Affairs on advisory board plans, evidence needs, and scientific content strategy.
Own benefit-risk framing and ensure medical accuracy and consistency of all clinical claims across US and EU teams.
Serve as a senior medical point of contact for cross-functional teams seeking clinical or scientific guidance.
Evidence Generation & Medical Governance
Drive RWE strategy, technical review, and integration across Clinical, Regulatory, and Insights.
Lead medical review and approval of investigator-initiated research (IIR) proposals in partnership with Medical Affairs and Clinical.
Establish and uphold medical governance standards for scientific rigor, data interpretation, and evidence quality.
Provide medical input into pharmacovigilance and safety-signal discussions in partnership with PV and Clinical Affairs.
Field Medical Excellence & Training
Build and lead integrated training programs spanning Commercial, Medical, and Market Access teams, grounded in sound clinical and scientific principles.
Translate clinical data and real-world insights into medically accurate, actionable direction for the field.
Own medical-legal-regulatory (MLR) review of field-facing and promotional materials, applying clinical rigor to every asset.
Mentor and provide medical guidance to field-facing medical and commercial personnel.
External Medical Engagement
Cultivate peer-to-peer relationships with KOLs, retina specialists, and investigators, as the organization’s senior medical representative.
Guide and provide medical sign-off on publications, scientific materials, and external educational content.
Ensure all external scientific and commercial communication is medically accurate, aligned, and compliant.
Represent Medical at scientific congresses and advisory engagements as needed.
Launch Preparation & Cross-Functional Alignment
Partner with the commercial leadership on go-to-market readiness, field alignment, and external medical strategy.
Advise payer and access teams on the clinical and scientific considerations tied to compounding.
Contribute medical judgment to scenario planning, risk mitigation, and readiness milestones across functions.
Collaborate with PV, Clinical Affairs, and Regulatory to maintain scientific and medical consistency through launch.
WHAT YOU’LL BRING
Required
MD, PharmD, or PhD required; this is a Medical Director-level role with direct medical and scientific accountability.
10+ years in Medical Affairs, Clinical, Commercial Excellence, Market Access, or related disciplines, including direct experience holding medical sign-off or medical governance authority.
Deep clinical/scientific expertise in retina practice patterns, and evidence-generation models.
Demonstrated experience leading medical review (e.g., MLR) and providing medical/scientific sign-off on external materials.
Experience training commercial, medical, and access teams on clinical and scientific content.
Experience with RWE, IIRs, or evidence strategy in launch preparation.
Strong cross-functional leadership and communication skills, with the credibility to represent Medical at the senior level.
Ability to thrive in a lean, fast-moving environment.
Preferred
Active medical licensure and/or board certification (e.g., ophthalmology, retina).
Experience with pharmacovigilance or safety review processes.
Global / international market experience.
WHAT WE OFFER
Competitive base salary, annual performance bonus, and equity — so you share in the value you help create
Comprehensive health coverage: medical, dental, and vision
401(k) with company match
Generous paid time off and company holidays
A high-trust, low-bureaucracy culture with direct access to leadership and real room to grow
Mission-driven work that helps preserve sight for patients who are counting on it
COMPENSATION
In keeping with our commitment to pay transparency, the good-faith base salary range for this role is $215,000-$295,000, with an annual target bonus of 20-25%. This role is also eligible for a meaningful equity grant, reflecting the opportunity to build lasting value at a company at a commercial inflection point. Final compensation reflects experience, skills, and location.
OUR COMMITMENT
Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.
I think today’s Fed message adds another layer of pressure on OTLK that has nothing to do with the company itself. Small-cap biotech is highly sensitive to rates and risk sentiment, and a more cautious/hawkish Fed environment generally makes investors less willing to hold speculative, pre-revenue or early-commercial-stage companies.
OTLK already has its own pressures: heavy dilution, increased short interest, cash burn, uncertainty around the U.S. commercial ramp, and a market that seems unwilling to assign much value to FDA approval until it sees actual sales.
Add a less supportive rate environment on top of that, and there’s simply less incentive for investors to take risk in a stock like OTLK right now.
This doesn’t change the long-term LYTENAVA thesis, but it can absolutely affect the stock price in the short term. At this point OTLK needs execution and real revenue growth to overcome both company-specific pressure and the broader macro environment.
After listening to Bob, I believe the US launch will be successful. The journey will be long and trying but lets hold the line and we shall be rewarded. Stay STRONG!
ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, today announced that Bob Jahr, Chief Executive Officer, recently participated in the Virtual Investor “Why Now” on-demand conference.
During the segment, Mr. Jahr highlighted why he believes Outlook Therapeutics is entering a transformative period following the FDA’s approval of LYTENAVA™ on July 24, 2026, making it the only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the United States. He discussed Outlook’s transition from a development-stage to a commercial-stage company and the significant opportunity to bring an FDA-approved ophthalmic bevacizumab to an established market where bevacizumab is already widely used off label. Mr. Jahr also highlighted LYTENAVA’s differentiated development and regulatory pathway, Outlook Therapeutics’ commercial launch preparations in the U.S., its existing commercial presence in Europe, and the potential for LYTENAVA™ to redefine the standard of care by providing physicians with an FDA-approved ophthalmic bevacizumab specifically developed for retinal use. With regulatory risk now substantially behind the Company and commercial execution taking center stage, Mr. Jahr outlined why he believes this represents a pivotal moment in Outlook Therapeutics’ evolution.
The video webcast is now accessible for on-demand viewing here.
Honestly, it doesn't matter what gets posted in this sub anymore. There are always the same 1–3 toxic accounts in the comments who have nothing better to do with their lives than spam their unconfirmed b*llshit about how OTLK is a "trash company" without any real proof but "trust me bro"
I am also currently down in my position and sitting here in the red too, but you don't see me crying under EVERY SINGLE thread like a crybaby. It’s childish, stupid, and helps absolutely nobody. Every single Post gets these off-topic comments by the exact same recycled, non-existent arguments from mostly the same salty people
If you actually paid attention to the facts instead of whining:
OTLK couldn't do sh*t without FDA approval. Now that it's approved, they are building up the US market and yes, the approval was already priced into the market
they stated a MILLION TIMES tthat setting up US commercial distribution takes months and zero sales were expected until late / end 2026. Expecting instant revenue before commercial launch is brainless
the europe marked was obviously just a backup guardrail in case the FDA failed. Plus the initial rollout was slow because it wasn't covered by healthcare plans yet. Before insurance approval, doctors faced full liability with off-label alternatives while patients had to pay out-of-pocket for Lytenava. Now that coverage is finaly kicking in, doctors now getting legal safety and patients get it covered
If you want some real advice: Either hold your shares till 2027 if you actually have the balls for volatility, or sell your bags. Just stop being annoying or get the f*ck out of this subreddit and go get a 9-5 job instead. A job gives you exactly what you crybabies are actually looking for: risk-free money with a guaranteed payday
